does tirzepatide increase metabolism did not impact metabolic adaptation in people with obesity, but increased fat oxidation The promise of tirzepatide: A

Real-world data splits the pattern by body type: leaner, non-diabetic users stop the drug more often and restart it less often than users with type 2 diabetes, while diabetic users regain less weight but lose more blood-sugar control. Retatrutides curve is expected to be steeper given the glucagon-arm fourth force the others dont carry

Although physiological levels of GLP-1 can improve glycemic control, pharmacological levels of GLP-1 must be reached to promote weight loss

Body composition may influence dosing requirements, though weight-based dosing has not been consistently employed in animal studies or limited human applications

This lack of coverage significantly limits access for seniors with obesity, contributing to the relatively low rate of usage (3.6%) among this group